Introduced in 1987, prostate-antigen screening (PSA) has resulted in over 1 million additional men being diagnosed and treated for prostate cancer – but most of these were likely overdiagnosed and should not have been treated, a new study in the Journal of the National Cancer Institute contends. Using data from the National Cancer Institute, H. […]
